Item Type | Name |
Academic Article
|
Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Jurkat Cells
|
Concept
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Hematopoietic Stem Cells
|
Concept
|
Precursor Cells, B-Lymphoid
|
Concept
|
Cell Death
|
Concept
|
Active Transport, Cell Nucleus
|
Concept
|
Receptors, Natural Killer Cell
|
Concept
|
NK Cell Lectin-Like Receptor Subfamily K
|
Concept
|
Cell Lineage
|
Concept
|
Receptors, Antigen, T-Cell
|
Concept
|
Neoplastic Stem Cells
|
Concept
|
NK Cell Lectin-Like Receptor Subfamily D
|
Concept
|
Erythroid Precursor Cells
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
Concept
|
Cell Nucleus
|
Concept
|
Cell Division
|
Concept
|
Leukemia, B-Cell
|
Concept
|
Cell Communication
|
Concept
|
Cell Degranulation
|
Concept
|
Cell Adhesion Molecules
|
Concept
|
Cell Survival
|
Concept
|
Receptors, Cell Surface
|
Concept
|
Cord Blood Stem Cell Transplantation
|
Concept
|
Cell Membrane
|
Concept
|
HL-60 Cells
|
Concept
|
Cell Culture Techniques
|
Concept
|
Peripheral Blood Stem Cell Transplantation
|
Concept
|
Myeloid Progenitor Cells
|
Concept
|
K562 Cells
|
Concept
|
Th1 Cells
|
Concept
|
Lymphoma, B-Cell
|
Concept
|
Dendritic Cells
|
Concept
|
Killer Cells, Lymphokine-Activated
|
Concept
|
Stem Cell Transplantation
|
Concept
|
Stromal Cells
|
Concept
|
Embryonic Stem Cells
|
Concept
|
Cell Line
|
Concept
|
Cell Compartmentation
|
Concept
|
Tumor Cells, Cultured
|
Concept
|
Cell Differentiation
|
Concept
|
Lymphoid Progenitor Cells
|
Concept
|
Bone Marrow Cells
|
Concept
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
Concept
|
Pluripotent Stem Cells
|
Concept
|
NK Cell Lectin-Like Receptor Subfamily C
|
Concept
|
NK Cell Lectin-Like Receptor Subfamily B
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
Concept
|
Myeloid Cells
|
Concept
|
Killer Cells, Natural
|
Concept
|
Cell Line, Tumor
|
Concept
|
Antibody-Dependent Cell Cytotoxicity
|
Concept
|
HT29 Cells
|
Concept
|
Cells, Cultured
|
Concept
|
Stem Cells
|
Concept
|
Cell Separation
|
Concept
|
Natural Killer T-Cells
|
Concept
|
Cell Proliferation
|
Concept
|
Cell Count
|
Academic Article
|
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.
|
Academic Article
|
NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.
|
Academic Article
|
Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies.
|
Academic Article
|
Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.
|
Academic Article
|
Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
|
Academic Article
|
Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone.
|
Academic Article
|
Treatment of relapsed acute lymphoblastic leukemia: approaches used by pediatric oncologists and bone marrow transplant physicians.
|
Academic Article
|
Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.
|
Academic Article
|
The effects of 1,25-dihydroxyvitamin D3 on in vitro human NK cell development from hematopoietic stem cells.
|
Academic Article
|
The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells.
|
Academic Article
|
The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.
|
Academic Article
|
Use of natural killer cells as immunotherapy for leukaemia.
|
Academic Article
|
Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL.
|
Academic Article
|
Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation.
|
Academic Article
|
Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction.
|
Academic Article
|
Notch signaling at later stages of NK cell development enhances KIR expression and functional maturation.
|
Academic Article
|
HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research.
|
Academic Article
|
Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation.
|
Academic Article
|
Umbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional.
|
Academic Article
|
Pericardial effusion after pediatric hematopoietic cell transplant.
|
Academic Article
|
Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.
|
Academic Article
|
Peritransplant palifermin use and lymphocyte recovery after T-cell replete, matched related allogeneic hematopoietic cell transplantation.
|
Academic Article
|
Impact of long-term cryopreservation on single umbilical cord blood transplantation outcomes.
|
Academic Article
|
Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD.
|
Academic Article
|
Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failure.
|
Academic Article
|
Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation.
|
Academic Article
|
An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation outcomes.
|
Academic Article
|
Allogeneic hematopoietic cell transplantation in first remission abrogates poor outcomes associated with high-risk pediatric acute myeloid leukemia.
|
Academic Article
|
Outcome of CNS and pulmonary enteroviral infections after hematopoietic cell transplantation.
|
Academic Article
|
Natural killer-cell differentiation by myeloid progenitors.
|
Academic Article
|
KIR B or not to be?...that is the question for ALL.
|
Academic Article
|
One-unit versus two-unit cord-blood transplantation for hematologic cancers.
|
Academic Article
|
Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells.
|
Academic Article
|
Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.
|
Academic Article
|
The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).
|
Academic Article
|
Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.
|
Academic Article
|
Natural killer cell consolidation for acute myelogenous leukemia: a cell therapy ready for prime time?
|
Academic Article
|
Recent developments in cell-based immune therapy for neuroblastoma.
|
Academic Article
|
Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade.
|
Academic Article
|
A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation.
|
Academic Article
|
Pulmonary cytolytic thrombi after allogeneic hematopoietic cell transplantation: a further histologic description.
|
Academic Article
|
Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.
|
Academic Article
|
Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition.
|
Academic Article
|
Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia.
|
Academic Article
|
Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.
|
Academic Article
|
Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells.
|
Academic Article
|
Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation.
|
Academic Article
|
Clinical utility of natural killer cells in cancer therapy and transplantation.
|
Academic Article
|
Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis.
|
Academic Article
|
Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue.
|
Academic Article
|
Immunotherapy for pediatric cancer.
|
Academic Article
|
Successful remission rates and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation.
|
Academic Article
|
Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methods.
|
Academic Article
|
How do we define complete remission for acute myeloid leukemia in the current era? Results of an international survey.
|
Academic Article
|
Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model of human prostate cancer.
|
Academic Article
|
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.
|
Academic Article
|
Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.
|
Academic Article
|
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
|
Academic Article
|
The role of oxidant injury in the pathophysiology of human thalassemias.
|
Academic Article
|
Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia.
|
Academic Article
|
Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.
|
Academic Article
|
Allogeneic hematopoietic stem cell transplantation overcomes the adverse prognostic impact of CD20 expression in acute lymphoblastic leukemia.
|
Academic Article
|
Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.
|
Academic Article
|
Is It Better to Be Rich or Relaxed? Sociobiology Meets Bone Marrow Transplant.
|
Academic Article
|
Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.
|
Academic Article
|
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.
|
Academic Article
|
Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.
|
Academic Article
|
Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production.
|
Academic Article
|
Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.
|
Academic Article
|
Novel approaches to prevent leukemia relapse following allogeneic hematopoietic cell transplantation.
|
Academic Article
|
Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.
|
Academic Article
|
Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in?vivo cytokine administration: implications for clinical therapy.
|
Academic Article
|
Natural Killer Cell Adoptive Transfer Therapy: Exploiting the First Line of Defense Against Cancer.
|
Academic Article
|
Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.
|
Academic Article
|
iTRAQ is a useful method to screen for membrane-bound proteins differentially expressed in human natural killer cell types.
|
Academic Article
|
The epic race to immune reconstitution.
|
Academic Article
|
Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDS.
|
Academic Article
|
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.
|
Academic Article
|
Marrow damage and hematopoietic recovery following allogeneic bone marrow transplantation for acute leukemias: Effect of radiation dose and conditioning regimen.
|
Academic Article
|
Killing the killer: natural killer cells to treat Ewing's sarcoma.
|
Academic Article
|
Peripheral dose heterogeneity due to the thread effect in total marrow irradiation with helical tomotherapy.
|
Academic Article
|
A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia.
|
Academic Article
|
Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.
|
Academic Article
|
Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
|
Academic Article
|
Phase I study of a bispecific ligand-directed toxin targeting CD22 and CD19 (DT2219) for refractory B-cell malignancies.
|
Academic Article
|
Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
|
Academic Article
|
Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survival.
|
Academic Article
|
Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.
|
Academic Article
|
Acquisition, preparation, and functional assessment of human NK cells for adoptive immunotherapy.
|
Academic Article
|
Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.
|
Academic Article
|
The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.
|
Academic Article
|
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function.
|
Academic Article
|
Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors.
|
Academic Article
|
Lineage relationships of human interleukin-22-producing CD56+ ROR?t+ innate lymphoid cells and conventional natural killer cells.
|
Academic Article
|
Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression.
|
Academic Article
|
Costs of pediatric allogeneic hematopoietic-cell transplantation.
|
Academic Article
|
CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases.
|
Academic Article
|
Similar outcomes between adolescent/young adults and children with AML following allogeneic hematopoietic cell transplantation.
|
Academic Article
|
Lower leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant.
|
Academic Article
|
CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT.
|
Academic Article
|
A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD).
|
Academic Article
|
Factors predicting single-unit predominance after double umbilical cord blood transplantation.
|
Academic Article
|
Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation.
|
Academic Article
|
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.
|
Academic Article
|
Allogeneic hematopoietic cell transplantation outcomes for children with B-precursor acute lymphoblastic leukemia and early or late BM relapse.
|
Academic Article
|
Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival.
|
Academic Article
|
Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors.
|
Academic Article
|
High-unbound mycophenolic acid concentrations in an infant on peritoneal dialysis following hematopoietic cell transplant.
|
Academic Article
|
Visualization of tumor growth and response to NK-T cell based immunotherapy using bioluminescence.
|
Academic Article
|
Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells.
|
Academic Article
|
Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production.
|
Academic Article
|
Pediatric HIV infection and chronic myelogenous leukemia.
|
Academic Article
|
Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD.
|
Academic Article
|
Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients.
|
Academic Article
|
Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis.
|
Academic Article
|
Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma.
|
Academic Article
|
Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research.
|
Academic Article
|
Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning.
|
Academic Article
|
Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.
|
Academic Article
|
CD4+ T Cells Coexpressing CD134 (OX40) Harbor Significantly Increased Levels of Human Herpesvirus 6B DNA Following Umbilical Cord Blood Transplantation.
|
Academic Article
|
Loss of UHRF2 expression is associated with human neoplasia, promoter hypermethylation, decreased 5-hydroxymethylcytosine, and high proliferative activity.
|
Academic Article
|
Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.
|
Academic Article
|
Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.
|
Academic Article
|
YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome.
|
Academic Article
|
Erratum to: "Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction" [Biol Blood Marrow Transplant 2016;22:1159-1166].
|
Academic Article
|
Low day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation.
|
Academic Article
|
A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.
|
Academic Article
|
Matching at Human Leukocyte Antigen-C Improved the Outcomes after Double Umbilical Cord Blood Transplantation for Recipients of Two to Four of Six Human Leukocyte Antigen-Matched Grafts.
|
Academic Article
|
MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Marrow Transplant Research Study.
|
Academic Article
|
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.
|
Academic Article
|
Impact of Delayed Infusion Time in Umbilical Cord Blood Transplantation.
|
Academic Article
|
Investigating the Association of Genetic Admixture and Donor/Recipient Genetic Disparity with Transplant Outcomes.
|
Academic Article
|
Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models.
|
Academic Article
|
Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
|
Grant
|
Genetic epidemiology of hematopoietic cell transplant outcomes
|
Grant
|
ACTIVITY OF EXPANDED GAMMA/DELTA T CELLS
|
Grant
|
Biomarkers In Pediatric Versus Adult Myelodysplastic Syndromes
|
Grant
|
Lymphoid Tissue Inducer/NK22 Cells and Post-transplant Immune Recovery
|
Academic Article
|
Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells.
|
Academic Article
|
Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation.
|
Academic Article
|
Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402.
|
Academic Article
|
Dendritic Cell Recovery Impacts Outcomes after Umbilical Cord Blood and Sibling Donor Transplantation for Hematologic Malignancies.
|
Academic Article
|
Recipient T Cell Exhaustion and Successful Adoptive Transfer of Haploidentical Natural Killer Cells.
|
Academic Article
|
No association between donor telomere length and outcomes after allogeneic unrelated hematopoietic cell transplant in patients with acute leukemia.
|
Academic Article
|
Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis.
|
Academic Article
|
Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 Response.
|
Academic Article
|
Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation.
|
Academic Article
|
Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation.
|
Academic Article
|
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
|
Academic Article
|
Evaluation of a Machine Learning-Based Prognostic Model for Unrelated Hematopoietic Cell Transplantation Donor Selection.
|
Academic Article
|
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.
|
Academic Article
|
Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.
|
Academic Article
|
Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.
|
Academic Article
|
Treosulfan, Fludarabine, and Low-Dose Total Body Irradiation for Children and Young Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation: Prospective Phase II Trial of the Pediatric Blood and Marrow Transplant Consortium.
|
Academic Article
|
In silico prediction of nonpermissive HLA-DPB1 mismatches in unrelated HCT by functional distance.
|
Academic Article
|
Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes.
|
Academic Article
|
Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders.
|
Academic Article
|
Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia.
|
Academic Article
|
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia.
|
Academic Article
|
The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation - a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR.
|
Academic Article
|
Analysis of Single Nucleotide Polymorphisms in the Gamma Block of the Major Histocompatibility Complex in Association with Clinical Outcomes of Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study.
|
Academic Article
|
Monocyte Subpopulation Recovery as Predictors of Hematopoietic Cell Transplantation Outcomes.
|
Academic Article
|
Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients.
|
Academic Article
|
Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumors.
|
Academic Article
|
Mixed vs full donor engraftment early after hematopoietic cell transplant: Impact on incidence and control of cytomegalovirus infection.
|
Concept
|
Cell Self Renewal
|
Concept
|
Epithelial Cell Adhesion Molecule
|
Concept
|
Single-Cell Analysis
|
Concept
|
Cell- and Tissue-Based Therapy
|
Concept
|
Myeloid-Derived Suppressor Cells
|
Concept
|
HEK293 Cells
|
Concept
|
Primary Cell Culture
|
Academic Article
|
The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia.
|
Academic Article
|
Transient Expression of GATA3 in Hematopoietic Stem Cells Facilitates Helper Innate Lymphoid Cell Differentiation.
|
Academic Article
|
A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation.
|
Academic Article
|
Correction: A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation.
|
Academic Article
|
The Human TET2 Gene Contains Three Distinct Promoter Regions With Differing Tissue and Developmental Specificities.
|
Academic Article
|
Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia.
|
Academic Article
|
Donor HLA-E Status Associates with Disease-Free Survival and Transplant-Related Mortality after Non In Vivo T Cell-Depleted HSCT for Acute Leukemia.
|
Academic Article
|
Follistatin and Soluble Endoglin Predict 1-Year Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation.
|
Academic Article
|
More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling.
|
Academic Article
|
Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia.
|
Academic Article
|
Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
|
Academic Article
|
Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function.
|
Academic Article
|
Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia.
|
Academic Article
|
Prolactin Acts on Myeloid Progenitors to Modulate SMAD7 Expression and Enhance Hematopoietic Stem Cell Differentiation into the NK Cell Lineage.
|
Academic Article
|
Autoimmune cytopenias following allogeneic hematopoietic stem cell transplant in pediatric patients: Response to therapy and late effects.
|
Academic Article
|
Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant.
|
Academic Article
|
Human innate lymphoid cell precursors express CD48 that modulates ILC differentiation through 2B4 signaling.
|
Academic Article
|
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation.
|
Academic Article
|
Glycemic variability is associated with poor outcomes in pediatric hematopoietic stem cell transplant patients.
|
Grant
|
Characterizing Innate Immune Dysregulation in Tonsils of Individuals with Down Syndrome
|
Academic Article
|
Therapeutic manipulation of innate lymphoid cells.
|
Academic Article
|
Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation.
|
Academic Article
|
Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemia.
|
Academic Article
|
An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.
|
Academic Article
|
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.
|
Academic Article
|
Neither Donor nor Recipient Mitochondrial Haplotypes Are Associated with Unrelated Donor Transplant Outcomes: A Validation Study from the CIBMTR.
|
Academic Article
|
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia.
|
Academic Article
|
Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning.
|
Academic Article
|
Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia.
|
Academic Article
|
Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia.
|
Academic Article
|
Donor Killer Immunoglobulin Receptor Gene Content and Ligand Matching and Outcomes of Pediatric Patients with Juvenile Myelomonocytic Leukemia Following Unrelated Donor Transplantation.
|
Academic Article
|
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.
|
Academic Article
|
Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy.
|
Academic Article
|
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report.
|
Academic Article
|
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.
|
Academic Article
|
SAHA Enhances Differentiation of CD34+CD45+ Hematopoietic Stem and Progenitor Cells from Pluripotent Stem Cells Concomitant with an Increase in Hemogenic Endothelium.
|
Academic Article
|
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
|
Academic Article
|
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia.
|
Academic Article
|
Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy.
|
Academic Article
|
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium.
|
Academic Article
|
Can allogeneic haematopoietic cell transplantation be curative in classical Crohn's disease?
|
Academic Article
|
Time to transplantation and pediatric acute myeloid leukemia outcomes.
|
Academic Article
|
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia.
|
Academic Article
|
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL.
|
Academic Article
|
Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia.
|
Academic Article
|
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns.
|